Cover Page
Cover Page - shares | 6 Months Ended | |
Jul. 30, 2022 | Aug. 22, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jul. 30, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-16435 | |
Entity Registrant Name | Chico's FAS, Inc. | |
Entity Incorporation, State or Country Code | FL | |
Entity Tax Identification Number | 59-2389435 | |
Entity Address, Address Line One | 11215 Metro Parkway | |
Entity Address, City or Town | Fort Myers | |
Entity Address, State or Province | FL | |
Entity Address, Postal Zip Code | 33966 | |
City Area Code | 239 | |
Local Phone Number | 277-6200 | |
Title of 12(b) Security | Common Stock, Par Value $0.01 Per Share | |
Trading Symbol | CHS | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 125,093,219 | |
Amendment Flag | false | |
Entity Central Index Key | 0000897429 | |
Current Fiscal Year End Date | --01-29 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q2 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 30, 2022 | Jul. 31, 2021 | Jul. 30, 2022 | Jul. 31, 2021 | |
Income Statement [Abstract] | ||||
Net Sales | $ 558,720 | $ 472,059 | $ 1,099,635 | $ 860,020 |
Net Sales, as a Percentage | 100% | 100% | 100% | 100% |
Cost of goods sold | $ 327,206 | $ 290,601 | $ 651,556 | $ 551,767 |
Cost of goods sold, as a Percentage of Sales | 58.60% | 61.60% | 59.30% | 64.20% |
Gross Margin | $ 231,514 | $ 181,458 | $ 448,079 | $ 308,253 |
Gross Margin, as a Percentage of Sales | 41.40% | 38.40% | 40.70% | 35.80% |
Selling, general and administrative expenses | $ 173,297 | $ 145,849 | $ 344,455 | $ 280,168 |
Selling, general and administrative expenses, as a Percentage of Sales | 31% | 30.90% | 31.30% | 32.50% |
Income from Operations | $ 58,217 | $ 35,609 | $ 103,624 | $ 28,085 |
Income from Operations, as a Percentage of Sales | 10.40% | 7.50% | 9.40% | 3.30% |
Interest expense, net | $ (1,056) | $ (1,722) | $ (2,031) | $ (3,427) |
Interest expense, net, as a Percentage of Sales | (0.20%) | (0.30%) | (0.20%) | (0.40%) |
Income before Income Taxes | $ 57,161 | $ 33,887 | $ 101,593 | $ 24,658 |
Income before Income Taxes, as a Percentage of Sales | 10.20% | 7.20% | 9.20% | 2.90% |
Income tax provision | $ 15,200 | $ 7,700 | $ 24,700 | $ 7,400 |
Income tax provision, as a Percentage of Sales | 2.70% | 1.70% | 2.20% | 0.90% |
Net Income | $ 41,961 | $ 26,187 | $ 76,893 | $ 17,258 |
Net Income, as a Percentage of Sales | 7.50% | 5.50% | 7% | 2% |
Per Share Data: | ||||
Net income per common share - basic (in dollars per share) | $ 0.35 | $ 0.22 | $ 0.64 | $ 0.15 |
Net income per common and common equivalent share – diluted (in dollars per share) | $ 0.34 | $ 0.21 | $ 0.62 | $ 0.14 |
Weighted average common shares outstanding – basic (in shares) | 120,003 | 117,021 | 119,498 | 116,855 |
Weighted average common and common equivalent shares outstanding – diluted (in shares) | 123,897 | 122,723 | 123,580 | 121,222 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 30, 2022 | Jul. 31, 2021 | Jul. 30, 2022 | Jul. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 41,961 | $ 26,187 | $ 76,893 | $ 17,258 |
Other comprehensive income: | ||||
Unrealized gains (losses) on marketable securities, net of taxes | 5 | (20) | 5 | (54) |
Comprehensive income | $ 41,966 | $ 26,167 | $ 76,898 | $ 17,204 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Jul. 30, 2022 | Jan. 29, 2022 | Jul. 31, 2021 |
Current Assets: | |||
Cash and cash equivalents | $ 157,233 | $ 115,105 | $ 126,298 |
Marketable securities, at fair value | 15,301 | 0 | 10,891 |
Inventories | 338,761 | 323,389 | 202,128 |
Prepaid expenses and other current assets | 47,553 | 41,871 | 50,428 |
Income tax receivable | 12,654 | 13,698 | 41,698 |
Total Current Assets | 571,502 | 494,063 | 431,443 |
Property and Equipment, net | 181,093 | 195,332 | 208,925 |
Right of Use Assets | 438,959 | 463,077 | 529,945 |
Other Assets: | |||
Goodwill | 16,360 | 16,360 | 16,360 |
Other intangible assets, net | 5,000 | 5,000 | 5,000 |
Other assets, net | 19,599 | 23,005 | 21,394 |
Total Other Assets | 40,959 | 44,365 | 42,754 |
Total Assets | 1,232,513 | 1,196,837 | 1,213,067 |
Current Liabilities: | |||
Accounts payable | 173,891 | 180,828 | 119,387 |
Current lease liabilities | 165,345 | 172,506 | 163,376 |
Other current and deferred liabilities | 143,181 | 134,051 | 126,254 |
Total Current Liabilities | 482,417 | 487,385 | 409,017 |
Noncurrent Liabilities: | |||
Long-term debt | 99,000 | 99,000 | 149,000 |
Long-term lease liabilities | 350,797 | 381,081 | 454,164 |
Other noncurrent and deferred liabilities | 2,422 | 7,867 | 13,800 |
Total Noncurrent Liabilities | 452,219 | 487,948 | 616,964 |
Commitments and Contingencies (see Note 10) | |||
Shareholders’ Equity: | |||
Preferred stock, $0.01 par value; 2,500 shares authorized; no shares issued and outstanding | 0 | 0 | 0 |
Common stock, $0.01 par value; 400,000 shares authorized; 166,481 and 163,823 and 163,862 shares issued respectively; and 125,184 and 122,526 and 122,565 shares outstanding, respectively | 1,252 | 1,225 | 1,226 |
Additional paid-in capital | 508,105 | 508,654 | 503,168 |
Treasury stock, at cost, 41,297 shares, respectively | (494,395) | (494,395) | (494,395) |
Retained earnings | 282,910 | 206,020 | 177,077 |
Accumulated other comprehensive gain | 5 | 0 | 10 |
Total Shareholders’ Equity | 297,877 | 221,504 | 187,086 |
Total Liabilities and Shareholders' Equity | $ 1,232,513 | $ 1,196,837 | $ 1,213,067 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) - Parenthetical - $ / shares | Jul. 30, 2022 | Jan. 29, 2022 | Jul. 31, 2021 |
Statement of Financial Position [Abstract] | |||
Preferred share par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 |
Preferred shares authorized (in shares) | 2,500,000 | 2,500,000 | 2,500,000 |
Preferred shares issued (in shares) | 0 | 0 | 0 |
Preferred shares outstanding (in shares) | 0 | 0 | 0 |
Common share par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 |
Common shares authorized (in shares) | 400,000,000 | 400,000,000 | 400,000,000 |
Common shares issued (in shares) | 166,481,000 | 163,823,000 | 163,862,000 |
Common shares outstanding (in shares) | 125,184,000 | 122,526,000 | 122,565,000 |
Treasury shares at cost (in shares) | 41,297,000 | 41,297,000 | 41,297,000 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Gain |
Beginning Balance (in shares) at Jan. 30, 2021 | 119,735 | |||||
Treasury stocks, beginning balance (in shares) at Jan. 30, 2021 | 41,297 | |||||
Beginning Balance at Jan. 30, 2021 | $ 165,119 | $ 1,197 | $ 498,488 | $ (494,395) | $ 159,765 | $ 64 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 17,258 | 17,258 | ||||
Unrealized gains (losses) on marketable securities, net of taxes | (54) | (54) | ||||
Issuance of common stock (in shares) | 3,148 | |||||
Issuance of common stock | 0 | $ 32 | (32) | |||
Dividends on common stock | 54 | 54 | ||||
Repurchase of common stock & tax withholdings related to share-based awards (in shares) | (318) | |||||
Repurchase of common stock & tax withholdings related to share-based awards | (980) | $ (3) | (977) | |||
Share-based compensation | $ 5,689 | 5,689 | ||||
Treasury stocks, ending balance (in shares) at Jul. 31, 2021 | 41,297 | |||||
Ending Balance (in shares) at Jul. 31, 2021 | 122,565 | 122,565 | ||||
Ending Balance at Jul. 31, 2021 | $ 187,086 | $ 1,226 | 503,168 | $ (494,395) | 177,077 | 10 |
Beginning Balance (in shares) at May. 01, 2021 | 122,566 | |||||
Treasury stocks, beginning balance (in shares) at May. 01, 2021 | 41,297 | |||||
Beginning Balance at May. 01, 2021 | 158,282 | $ 1,226 | 500,453 | $ (494,395) | 150,968 | 30 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 26,187 | 26,187 | ||||
Unrealized gains (losses) on marketable securities, net of taxes | (20) | (20) | ||||
Issuance of common stock (in shares) | 23 | |||||
Issuance of common stock | (1) | (1) | ||||
Dividends on common stock | (78) | (78) | ||||
Repurchase of common stock & tax withholdings related to share-based awards (in shares) | (24) | |||||
Repurchase of common stock & tax withholdings related to share-based awards | (158) | (158) | ||||
Share-based compensation | $ 2,874 | 2,874 | ||||
Treasury stocks, ending balance (in shares) at Jul. 31, 2021 | 41,297 | |||||
Ending Balance (in shares) at Jul. 31, 2021 | 122,565 | 122,565 | ||||
Ending Balance at Jul. 31, 2021 | $ 187,086 | $ 1,226 | 503,168 | $ (494,395) | 177,077 | 10 |
Beginning Balance (in shares) at Jan. 29, 2022 | 122,526 | 122,526 | ||||
Treasury stocks, beginning balance (in shares) at Jan. 29, 2022 | 41,297 | |||||
Beginning Balance at Jan. 29, 2022 | $ 221,504 | $ 1,225 | 508,654 | $ (494,395) | 206,020 | 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 76,893 | 76,893 | ||||
Unrealized gains (losses) on marketable securities, net of taxes | 5 | 5 | ||||
Issuance of common stock (in shares) | 4,255 | |||||
Issuance of common stock | 156 | $ 43 | 113 | |||
Dividends on common stock | (3) | (3) | ||||
Repurchase of common stock & tax withholdings related to share-based awards (in shares) | (1,597) | |||||
Repurchase of common stock & tax withholdings related to share-based awards | (7,835) | $ (16) | (7,819) | |||
Share-based compensation | $ 7,157 | 7,157 | ||||
Treasury stocks, ending balance (in shares) at Jul. 30, 2022 | 41,297 | |||||
Ending Balance (in shares) at Jul. 30, 2022 | 125,184 | 125,184 | ||||
Ending Balance at Jul. 30, 2022 | $ 297,877 | $ 1,252 | 508,105 | $ (494,395) | 282,910 | 5 |
Beginning Balance (in shares) at Apr. 30, 2022 | 125,161 | |||||
Treasury stocks, beginning balance (in shares) at Apr. 30, 2022 | 41,297 | |||||
Beginning Balance at Apr. 30, 2022 | 252,778 | $ 1,251 | 504,977 | $ (494,395) | 240,945 | 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 41,961 | 41,961 | ||||
Unrealized gains (losses) on marketable securities, net of taxes | 5 | 5 | ||||
Issuance of common stock (in shares) | 59 | |||||
Issuance of common stock | 13 | $ 1 | 12 | |||
Dividends on common stock | 4 | 4 | ||||
Repurchase of common stock & tax withholdings related to share-based awards (in shares) | (36) | |||||
Repurchase of common stock & tax withholdings related to share-based awards | (177) | (177) | ||||
Share-based compensation | $ 3,293 | 3,293 | ||||
Treasury stocks, ending balance (in shares) at Jul. 30, 2022 | 41,297 | |||||
Ending Balance (in shares) at Jul. 30, 2022 | 125,184 | 125,184 | ||||
Ending Balance at Jul. 30, 2022 | $ 297,877 | $ 1,252 | $ 508,105 | $ (494,395) | $ 282,910 | $ 5 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Jul. 30, 2022 | Jul. 31, 2021 | |
Cash Flows from Operating Activities: | ||
Net income | $ 76,893 | $ 17,258 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Inventory write-offs | 434 | 374 |
Depreciation and amortization | 22,886 | 27,348 |
Non-cash lease expense | 90,293 | 95,317 |
Loss on disposal and impairment of property and equipment, net | 2,126 | 1,335 |
Deferred tax benefit | (432) | 250 |
Share-based compensation expense | 7,157 | 5,689 |
Changes in assets and liabilities: | ||
Inventories | (15,806) | 1,481 |
Prepaid expenses and other assets | (1,136) | (8,165) |
Income tax receivable | 1,044 | 16,442 |
Accounts payable | (6,635) | 2,991 |
Accrued and other liabilities | 2,683 | 6,259 |
Lease liability | (103,508) | (132,549) |
Net cash provided by operating activities | 75,999 | 34,030 |
Cash Flows from Investing Activities: | ||
Purchases of marketable securities | (16,324) | (219) |
Proceeds from sale of marketable securities | 1,029 | 7,826 |
Purchases of property and equipment | (10,191) | (5,150) |
Net cash (used in) provided by investing activities | (25,486) | 2,457 |
Cash Flows from Financing Activities: | ||
Payments of debt issuance costs | (706) | 0 |
Proceeds from issuance of common stock | 156 | 0 |
Payments of tax withholdings related to share-based awards | (7,835) | (980) |
Net cash used in financing activities | (8,385) | (980) |
Net increase in cash and cash equivalents | 42,128 | 35,507 |
Cash and Cash Equivalents, Beginning of period | 115,105 | 90,791 |
Cash and Cash Equivalents, End of period | 157,233 | 126,298 |
Supplemental Disclosures of Cash Flow Information: | ||
Cash paid for interest | 2,415 | 3,053 |
Cash (paid) received for income taxes, net | $ (16,559) | $ 15,976 |
Basis of Presentation and Summa
Basis of Presentation and Summary of Significant Accounting Policies | 6 Months Ended |
Jul. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation and Summary of Significant Accounting Policies | BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The accompanying unaudited condensed consolidated financial statements of Chico's FAS, Inc., a Florida corporation, and its wholly-owned subsidiaries (the "Company") have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, such interim financial statements reflect all normal, recurring adjustments considered necessary to present fairly the condensed consolidated financial position, the results of operations and cash flows for the interim periods presented. All significant intercompany balances and transactions have been eliminated in consolidation. The fiscal year ended January 29, 2022 balance sheet data was derived from audited consolidated financial statements. For further information, refer to the consolidated financial statements and notes thereto for the fiscal year ended January 29, 2022, included in the Company's Annual Report on Form 10-K for the fiscal year ended January 29, 2022 filed with the Securities and Exchange Commission ("SEC") on March 15, 2022 ("2021 Annual Report on Form 10-K"). As used in this report, all references to "we," "us," "our", "the Company" and "Chico's FAS," refer to Chico's FAS, Inc. and all of its wholly-owned subsidiaries. Our fiscal years end on the Saturday closest to January 31 and are designated by the calendar year in which the fiscal year commences. Operating results for the thirteen and twenty-six weeks ended July 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. COVID-19 Pandemic Update The novel strain of coronavirus (‘‘COVID-19’’) pandemic (the ‘‘COVID-19 pandemic’’ or the ‘‘pandemic’’) resulted in significant challenges across our business since March 2020 and is expected to continue to disrupt our business operations for fiscal 2022 to varying degrees. In response to the pandemic, many of our markets imposed limitations, varying by market and in frequency, on the access to the Company’s store fleet, including temporary store closures and/or a reduction in hours, staffing and capacity. We continue to focus on evolving consumer demand emerging from the pandemic and have accelerated our transformation to a digital-first company, fast-tracking numerous innovation and technology investments across all three of our brands. Even as governmental restrictions have relaxed and markets are primarily open, we expect continued uncertainty and volatility on our business operations, operating results and operating cash flows as the ongoing economic impacts and health concerns associated with the pandemic continue to affect consumer behavior, spending levels and shopping preferences and cause disruptions to the supply chain and increase our raw materials and freight costs. Due to the uncertainty over the duration and severity of the economic and operational impacts of the pandemic, the adverse impacts of the pandemic may continue throughout our fiscal year 2022. Reclassifications Certain reclassifications have been made to the prior period's financial statements to enhance the comparability with the current year's financial statements. As a result, certain line items have been amended in the unaudited condensed consolidated balance sheets to conform to the current period's presentation. Adoption of New Accounting Pronouncements There were no new accounting pronouncements adopted by the Company during the thirteen and twenty-six weeks ended July 30, 2022. |
Recently Issued Accounting Pron
Recently Issued Accounting Pronouncements | 6 Months Ended |
Jul. 30, 2022 | |
Accounting Changes and Error Corrections [Abstract] | |
Recently Issued Accounting Pronouncements | RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS The Company currently has no material recent accounting pronouncements yet to be adopted. |
Revenue Recognition
Revenue Recognition | 6 Months Ended |
Jul. 30, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | REVENUE RECOGNITION Disaggregated Revenue The following table disaggregates our operating segment revenue by brand, which we believe provides a meaningful depiction of the nature of our revenue. Amounts shown include licensing and wholesale revenue, which is not a significant component of total revenue, and is aggregated within the respective brands in the table below. Thirteen Weeks Ended Twenty-Six Weeks Ended July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Chico's $ 281,777 50.4 % $ 221,389 46.9 % $ 546,243 49.7 % $ 398,410 46.3 % WHBM 158,581 28.4 122,043 25.9 327,610 29.8 226,090 26.3 Soma 118,362 21.2 128,627 27.2 225,782 20.5 235,520 27.4 Total Net Sales $ 558,720 100.0 % $ 472,059 100.0 % $ 1,099,635 100.0 % $ 860,020 100.0 % Contract Liability Contract liabilities in the unaudited condensed consolidated balance sheets are comprised of obligations associated with our gift card and customer loyalty programs. As of July 30, 2022, January 29, 2022 and July 31, 2021, contract liabilities primarily consisted of gift cards of $33.7 million, $43.5 million and $33.8 million, respectively. For the thirteen and twenty-six weeks ended July 30, 2022, the Company recognized $8.5 million and $20.0 million, respectively, of revenue that was previously included in the gift card contract liability as of January 29, 2022. For the thirteen and twenty-six weeks ended July 31, 2021, the Company recognized $5.7 million and $15.7 million, respectively, of revenue that was previously included in the gift card contract liability as of January 30, 2021. The contract liability for our loyalty program was not material as of July 30, 2022, January 29, 2022 or July 31, 2021. Performance Obligation |
Leases
Leases | 6 Months Ended |
Jul. 30, 2022 | |
Leases [Abstract] | |
Leases | LEASES We lease retail stores, a limited amount of office space and certain equipment under operating leases expiring in various years through the fiscal year ending 2032. All of our leases have been classified as operating leases and are recognized and measured as such. Certain operating leases provide for renewal options that are at a pre-determined period and rental value. Furthermore, certain leases provide that we may cancel the lease if our retail sales at that location fall below an established level. Within the first few years of the initial lease term, a majority of our store operating leases contain cancellation clauses that allow the leases to be terminated at our discretion, if certain minimum sales levels are not met. In the normal course of business, operating leases are typically renewed or replaced by other leases. Escalation of operating lease payments of certain leases depend on an existing index or rate, such as the consumer price index or the market interest rate. These are considered variable lease payments and are included in lease payments when the escalation is known. In April 2020, the FASB granted a practical expedient permitting an entity to choose to forgo the evaluation of the enforceable rights and obligations of the original lease contract, specifically in situations where rent concessions have been agreed to with landlords as a result of the pandemic. Instead, the entity may account for pandemic-related rent concessions, whatever their form (e.g. rent deferral, abatement or other) either: a) as if they were part of the enforceable rights and obligations of the parties under the existing lease contract; or b) as lease modifications. During the thirteen and twenty-six weeks ended July 31, 2021, we received concessions from certain landlords in the form of rent deferrals, rent abatements and other lease or rent modifications as a result of the ongoing impact of the pandemic. In accordance with the practical expedient allowed by the FASB, the Company elected to treat all pandemic-related rent concessions and related amendments, including pandemic-related lease amendments that extended the lease term, as lease modifications under ASC 842, Leases. In addition, the Company continued recording lease expense during deferral periods, as applicable, in accordance with its existing policies. Operating lease expense was as follows: Thirteen Weeks Ended Twenty-Six Weeks Ended July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Operating lease cost (1) $ 54,247 $ 55,341 $ 107,663 $ 110,747 (1) For the thirteen and twenty-six weeks ended July 30, 2022, includes $9.6 million and $19.1 million, respectively, in variable lease costs. For the thirteen and twenty-six weeks ended July 31, 2021, includes $9.3 million and $19.2 million, respectively, in variable lease costs. Supplemental balance sheet information related to operating leases was as follows: July 30, 2022 January 29, 2022 July 31, 2021 Right of use assets $ 438,959 $ 463,077 $ 529,945 Current lease liabilities $ 165,345 $ 172,506 $ 163,376 Long-term lease liabilities 350,797 381,081 454,164 Total operating lease liabilities $ 516,142 $ 553,587 $ 617,540 Weighted Average Remaining Lease Term (years) 4.0 4.0 4.2 Weighted Average Discount Rate (1) 4.6 % 4.5 % 4.6 % (1) The incremental borrowing rate used by the Company is based on the rate at which the Company could borrow funds using its credit rating for a collateralized loan of similar term to the lease. The weighted average discount rate represents a weighted average of the incremental borrowing rate for each lease weighted based on the remaining fixed lease obligations. Supplemental cash flow information related to operating leases was as follows: Twenty-Six Weeks Ended July 30, 2022 July 31, 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflows $ 103,508 $ 132,549 Right of use assets obtained in exchange for lease obligations, non-cash 54,336 24,297 Maturities of operating lease liabilities as of July 30, 2022 were as follows: Fiscal Year Ending: January 28, 2023 $ 99,596 February 4, 2024 166,504 February 1, 2025 121,141 January 31, 2026 78,879 January 30, 2027 51,307 Thereafter 53,578 Total future minimum lease payments $ 571,005 Less imputed interest (54,863) Total $ 516,142 |
Share-Based Compensation
Share-Based Compensation | 6 Months Ended |
Jul. 30, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Share-Based Compensation | SHARE-BASED COMPENSATION For the twenty-six weeks ended July 30, 2022 and July 31, 2021, share-based compensation expense was $7.2 million and $5.7 million, respectively. As of July 30, 2022, approximately 6.6 million shares remain available for future grants of equity awards under our 2020 Omnibus Stock and Incentive Plan. Restricted Stock Awards Restricted stock awards vest in equal annual installments over a three-year period from the date of grant, except for a restricted stock award granted to our then Chief Executive Officer in fiscal 2019, which vests over a four-year period from the date of grant, and restricted stock awards granted in March 2021, which vest 50% one year from the date of grant, 30% two years from the date of grant and 20% three years from the date of grant. Restricted stock award activity for the twenty-six weeks ended July 30, 2022 was as follows: Number of Weighted Unvested, beginning of period 5,140,240 $ 3.18 Granted 2,572,233 4.78 Vested (2,347,510) 3.26 Forfeited (341,303) 3.59 Unvested, end of period 5,023,660 3.93 Restricted Stock Units Restricted stock units vest 100% one year from the date of grant with certain rights to defer settlement in shares of our common stock, except for restricted stock units granted in March 2021, which vest 50% one year from the date of grant, 30% two years from the date of grant and 20% three years from the date of grant, and restricted stock units granted in March 2022, which vest in equal annual installments over a three-year period from the date of grant. Restricted stock unit activity for the twenty-six weeks ended July 30, 2022 was as follows: Number of Weighted Unvested, beginning of period 647,350 $ 2.38 Granted 47,468 4.74 Vested (288,600) 2.66 Unvested, end of period 406,218 2.46 Performance-based Restricted Stock Units During the twenty-six weeks ended July 30, 2022, we granted performance-based restricted stock units ("PSUs") contingent upon the achievement of Company-specific performance goals during the three fiscal years 2022 through 2024. Any units earned as a result of the achievement of the performance goals of the PSUs will vest three years from the date of grant and will be settled in shares of our common stock. PSU activity for the twenty-six weeks ended July 30, 2022 was as follows: Number of Units/ Weighted Unvested, beginning of period 3,734,207 $ 2.24 Granted 1,082,050 3.85 Vested (1,697,130) 1.16 Forfeited (434,122) 2.96 Unvested, end of period 2,685,005 3.45 |
Income Taxes
Income Taxes | 6 Months Ended |
Jul. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | INCOME TAXES The provision for income taxes is based on a current estimate of the annual effective tax rate and is adjusted as necessary for quarterly events. Our effective income tax rate may fluctuate from quarter to quarter as a result of a variety of factors, including changes in our assessment of certain tax contingencies, valuation allowances, changes in tax law, outcomes of administrative audits, the impact of discrete items and the mix of earnings across jurisdictions. For the thirteen weeks ended July 30, 2022 and July 31, 2021, the Company's effective tax rate was 26.6% and 22.7%, respectively. The effective tax rate of 26.6% for the thirteen weeks ended July 30, 2022 primarily reflects the impact of losses in foreign jurisdictions on which a full valuation allowance is recorded. The 22.7% effective tax rate for the thirteen weeks ended July 31, 2021 primarily reflects a change in estimate from the first quarter of fiscal 2021 due to an increase in the Company’s projected annual pre-tax income and an increase in annual projected deferred tax assets on which a full valuation allowance exists, partially offset by the impact of the annual loss projected during the first quarter of fiscal 2021. For the twenty-six weeks ended July 30, 2022 and July 31, 2021, the Company's effective tax rate was 24.3% and 30.0%, respectively. The effective tax rate of 24.3% for the twenty-six weeks ended July 30, 2022 primarily reflects a favorable share-based compensation benefit and a reduction in the liability for future reversing deferred tax liabilities. The 30.0% effective tax rate for the twenty-six weeks ended July 31, 2021 primarily reflects a change in the estimate from the first quarter of fiscal 2021 due to an increase in the Company’s projected annual pre-tax income and an increase in annual projected deferred tax assets on which a full valuation allowance exists, partially offset by the impact of the annual loss projected during the first quarter of fiscal 2021 and favorable state audit settlements. |
Income Per Share
Income Per Share | 6 Months Ended |
Jul. 30, 2022 | |
Earnings Per Share [Abstract] | |
Income Per Share | INCOME PER SHARE In accordance with relevant accounting guidance, unvested share-based payment awards that include non-forfeitable rights to dividends, whether paid or unpaid, are considered participating securities. As a result, such awards are required to be included in the calculation of income per common share pursuant to the "two-class" method. For the Company, participating securities are comprised entirely of unvested restricted stock awards granted prior to fiscal 2020. Net income per share is determined using the two-class method when it is more dilutive than the treasury stock method. Basic net income per share is computed by dividing net income available to common shareholders by the weighted-average number of common shares outstanding during the period, including participating securities. Diluted net income per share reflects the dilutive effect of potential common shares from non-participating securities such as restricted stock awards granted after fiscal 2019, stock options, PSUs and restricted stock units. The following table sets forth the computation of net income per basic and diluted share shown on the face of the accompanying condensed consolidated statements of income: Thirteen Weeks Ended Twenty-Six Weeks Ended July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Numerator Net income $ 41,961 $ 26,187 $ 76,893 $ 17,258 Net income allocated to participating securities (166) (235) (348) (171) Net income available to common shareholders $ 41,795 $ 25,952 $ 76,545 $ 17,087 Denominator (000's) Weighted average common shares outstanding – basic 120,003 117,021 119,498 116,855 Dilutive effect of non-participating securities 3,894 5,703 4,082 4,367 Weighted average common and common equivalent shares outstanding – diluted 123,897 122,723 123,580 121,222 Net income per common share: Basic $ 0.35 $ 0.22 $ 0.64 $ 0.15 Diluted $ 0.34 $ 0.21 $ 0.62 $ 0.14 For the thirteen weeks ended July 30, 2022 and July 31, 2021, 0.05 million and 0.1 million potential shares of common stock, respectively, were excluded from the diluted income per common share calculation relating to non-participating securities, because the effect of including these potential shares was antidilutive. For the twenty-six weeks ended July 30, 2022 and July 31, 2021, 0.1 million and 0.1 million potential shares of common stock, respectively, were excluded from the diluted income per common share calculation relating to non-participating securities, because the effect of including these potential shares was antidilutive. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jul. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | FAIR VALUE MEASUREMENTS Our financial instruments generally consist of cash, money market accounts, marketable securities, assets held in our non-qualified deferred compensation plan, accounts receivable and payable, and debt. Cash, accounts receivable and accounts payable are carried at cost, less reserves for credit losses as applicable, which approximates their fair value due to the short-term nature of the instruments. Marketable securities are classified as available-for-sale and as of July 30, 2022, consisted of U.S. government agencies, corporate bonds and commercial paper, with $8.8 million of securities with maturity dates within one year or less and $6.5 million with maturity dates over one year. We consider all marketable securities available-for-sale, including those with maturity dates beyond 12 months, and therefore classify these securities within current assets on the unaudited condensed consolidated balance sheets, as applicable, as they were available to support current operational liquidity needs. Marketable securities are carried at fair value, with the unrealized holding gains and losses, net of income taxes, reflected in accumulated other comprehensive gain until realized, and any credit risk related losses recognized in net income during the period incurred. For the purposes of computing realized and unrealized gains and losses, cost is determined on a specific identification basis. Fair value is defined as the price that would be received to sell an a set or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. Entities are required to use a three-level hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows: Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 — Unadjusted quoted prices in active markets for similar assets or liabilities; or Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or Inputs other than quoted prices that are observable for the asset or liability Level 3 — Unobservable inputs for the asset or liability Assets Measured on a Recurring Basis We measure certain financial assets at fair value on a recurring basis, including our marketable securities, as applicable, which are classified as available-for-sale securities, certain cash equivalents, specifically our money market accounts and assets held in our non-qualified deferred compensation plan, as applicable. The money market accounts are valued based on quoted market prices in active markets. Our marketable securities are generally valued based on other observable inputs for those securities (including market corroborated pricing or other models that utilize observable inputs such as interest rates and yield curves) based on information provided by independent third-party pricing entities, except for U.S. government securities which are valued based on quoted market prices in active markets. The investments in our non-qualified deferred compensation plan are valued using quoted market prices and are included in other assets on our unaudited condensed consolidated balance sheets. Assets Measured on a Nonrecurring Basis From time to time, we measure certain assets at fair value on a nonrecurring basis when carrying value exceeds fair value. This includes the evaluation of long-lived assets, goodwill and other intangible assets for impairment using Company-specific assumptions which would fall within Level 3 of the fair value hierarchy. Assets that are measured at fair value on a nonrecurring basis are remeasured when carrying value exceeds fair value. Carrying value after impairment approximates fair value. We assess the carrying amount of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses market participant rents and a market participant discount rate to calculate the fair value of ROU assets. The Company uses discounted future cash flows of the asset or asset group using a discount rate that approximates the cost of capital of a market participant to quantify fair value for other long-lived assets within the asset group, which are primarily leasehold improvements. The asset group is defined as the lowest level for which identifiable cash flows are available and largely independent of the cash flows of other groups of assets, which for our retail stores, is primarily at the store level. To assess the fair value of goodwill, we have historically utilized both an income approach and a market approach. Inputs used to calculate the fair value based on the income approach primarily include estimated future cash flows, discounted at a rate that approximates the cost of capital of a market participant. Inputs used to calculate the fair value based on the market approach include identifying sales and EBITDA multiples based on guidelines for similar publicly traded companies and recent transactions. To assess the fair value of trademarks, we utilize a relief from royalty approach. Inputs used to calculate the fair value of the trademarks primarily include future sales projections, discounted at a rate that approximates the cost of capital of a market participant and an estimated royalty rate. As of July 30, 2022, January 29, 2022 and July 31, 2021, our revolving loan and letter of credit facility approximates fair value as this instrument has a variable interest rate which approximates current market rates (Level 2 criteria). Fair value calculations contain significant judgments and estimates, which may differ from actual results due to, among other things, economic conditions, changes to the business model or changes in operating performance. The most sensitive assumptions in our estimates include short and long-term revenue recoverability rates as a result of the pandemic, which could impact future impairment charges. We conduct reviews on a quarterly basis to verify pricing, assess liquidity and determine if significant inputs have changed that would impact the fair value hierarchy disclosure. In accordance with the provisions of the guidance, we categorized our financial assets and liabilities which are valued on a recurring and nonrecurring basis, based on the priority of the inputs to the valuation technique for the instruments, as follows: Fair Value Measurements at the End of the Reporting Date Using Balance as of July 30, 2022 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring fair value measurements: Current Assets Cash equivalents: Money market accounts $ 35,195 $ 35,195 $ — $ — Marketable securities: U.S. government agencies 1,505 — 1,505 — Corporate bonds 5,948 — 5,948 — Commercial paper 7,848 — 7,848 — Deferred compensation plan 4,803 4,803 — — Total recurring fair value measurements $ 55,299 $ 39,998 $ 15,301 $ — Fair Value Measurements at the End of the Reporting Date Using Balance as of January 29, 2022 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring fair value measurements: Current Assets Cash equivalents: Money market accounts $ 25,396 $ 25,396 $ — $ — Noncurrent Assets Deferred compensation plan 6,233 6,233 — — Total recurring fair value measurements $ 31,629 $ 31,629 $ — $ — Fair Value Measurements at the End of the Reporting Date Using Balance as of July 31, 2021 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring fair value measurements: Current Assets Cash equivalents: Money market accounts $ 14,493 $ 14,493 $ — $ — Marketable securities: Corporate bonds 10,891 — 10,891 — Noncurrent Assets Deferred compensation plan 6,124 6,124 — — Total recurring fair value measurements $ 31,508 $ 20,617 $ 10,891 $ — Impairment charges for assets evaluated for impairment on a nonrecurring basis were not material during the twenty-six weeks ended July 30, 2022 and July 31, 2021 and for the fifty-two weeks ended January 29, 2022. |
Debt
Debt | 6 Months Ended |
Jul. 30, 2022 | |
Debt Disclosure [Abstract] | |
Debt | DEBTOn February 2, 2022, the Company and certain material domestic subsidiaries entered into Amendment No. 2 (the "Amendment") to its credit agreement (as amended, the "Credit Agreement") originally entered into on August 2, 2018 and amended October 30, 2020, by and among the Company, certain material domestic subsidiaries as co-borrowers and guarantors, Wells Fargo Bank, National Association ("Wells Fargo Bank"), as Agent, letter of credit issuer and swing line lender, and certain lenders party thereto. Our obligations under the Credit Agreement are guaranteed by the guarantors and are secured by a first priority lien on certain assets of the Company and certain material domestic subsidiaries, including inventory, accounts receivable, cash deposits, certain insurance proceeds, real estate, fixtures and certain intellectual property. The Credit Agreement provides for a five-year asset-based senior secured revolving loan ("ABL") and letter of credit facility of up to $285.0 million, maturing February 2, 2027. The interest rate applicable to Term Secured Overnight Financing Rate ("SOFR") Loans drawn under the ABL is equal to Term SOFR plus 1.60% (subject to a further decrease to Term SOFR plus 1.35% or an increase to Term SOFR plus 1.85% based upon average quarterly excess availability under the ABL). The Credit Agreement also provides for a $15.0 million first-in last-out ("FILO") loan. The interest rate applicable to the FILO is equal to Term SOFR plus 3.60% (subject to a further decrease to Term SOFR plus 3.35% or an increase to Term SOFR plus 3.85% based on average quarterly excess availability under the FILO). However, for any ABL or FILO with a SOFR interest rate period of six months, the interest rate applicable to the ABL and FILO is increased by 30 basis points. The Credit Agreement contains customary representations, warranties, and affirmative covenants, as well as customary negative covenants, that, among other things restrict, subject to certain exceptions, the ability of the Company and certain of its domestic subsidiaries to: (i) incur liens, (ii) make investments, (iii) issue or incur additional indebtedness, (iv) undergo significant corporate changes, including mergers and acquisitions, (v) make dispositions, (vi) make restricted payments, (vii) prepay other indebtedness and (viii) enter into certain other restrictive agreements. The Company may pay cash dividends and repurchase shares under its share buyback program, subject to certain thresholds of available borrowings based upon the lesser of the aggregate amount of commitments under the Credit Agreement and the borrowing base, determined after giving effect to any such transaction or payment, on a pro forma basis. In addition, the Company must pay a commitment fee per annum on the unused portion of the commitments under the Credit Agreement. As of July 30, 2022, $99.0 million in net borrowings were outstanding under the Credit Agreement. Availability under the Credit Agreement is determined based upon a monthly borrowing base calculation which includes eligible credit card receivables, real estate and inventory, less outstanding borrowings, letters of credit and certain designated reserves. As of July 30, 2022, the available additional borrowing capacity under the Credit Agreement was approximately $188.0 million, inclusive of the current loan cap of $30.0 million. As of July 30, 2022, deferred financing costs of $3.7 million was outstanding related to the Credit Agreement and is presented in other current assets in the accompanying unaudited condensed consolidated balance sheet. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jul. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | COMMITMENTS AND CONTINGENCIES In February 2021, the Company was named as a defendant in Mercedes Haldy, et al. v. White House Black Market, Inc. (‘‘WHBM’’), et al., a putative class action filed in the Superior Court of California, Orange County, and subsequently removed to the United States District Court, Central District of California (‘‘Haldy’’). The Haldy complaint alleges numerous violations of California law related to payment of wages and other compensation, meal periods, rest periods, and wage statements, among other things. Plaintiff seeks to represent a class of current and former nonexempt employees of WHBM and Chico’s stores in California. In August 2021, the Company was named as a defendant in Margarita Hernandez v. Chico’s FAS, Inc., et al., a putative class action filed in the Superior Court of California, Orange County seeking to represent a class of current and former nonexempt employees of Chico’s, WHBM and Soma stores in California (‘‘Hernandez’’). The Hernandez complaint alleges many of the same wage and labor violations as the Haldy complaint and seeks the same relief. During a mediation in September 2021, the Company reached an agreement in principle to settle the above cases. A Memorandum of Understanding was entered into by all parties as of October 18, 2021 and a full settlement agreement was executed by all parties as of January 10, 2022. On May 19, 2022, the Superior Court of California entered an Order granting the parties' unopposed motion for preliminary approval of the class settlement, and set October 14, 2022 as the hearing date for final approval of the settlement. Based on the foregoing, the Company does not expect that the resolution of these cases will have a material adverse effect on its business, results of operations or consolidated financial statements, but if the settlement agreement is not approved by the respective courts, the ultimate resolution of these cases could have a material adverse effect on the Company’s results of operations or consolidated financial statements. Other than as noted above, we are not currently a party to any material legal proceedings other than claims and lawsuits arising in the normal course of our business. All such matters are subject to uncertainties, and outcomes may not be predictable. Consequently, the ultimate aggregate amounts of monetary liability or financial impact with respect to other matters as of July 30, 2022 are not estimable. However, while such matters could affect our consolidated operating results when resolved in future periods, management believes that upon final disposition, any monetary liability or financial impact to us would not be material to our annual consolidated financial statements. |
Basis of Presentation and Sum_2
Basis of Presentation and Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Jul. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | The accompanying unaudited condensed consolidated financial statements of Chico's FAS, Inc., a Florida corporation, and its wholly-owned subsidiaries (the "Company") have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, such interim financial statements reflect all normal, recurring adjustments considered necessary to present fairly the condensed consolidated financial position, the results of operations and cash flows for the interim periods presented. All significant intercompany balances and transactions have been eliminated in consolidation. |
Reclassifications | Reclassifications Certain reclassifications have been made to the prior period's financial statements to enhance the comparability with the current year's financial statements. As a result, certain line items have been amended in the unaudited condensed consolidated balance sheets to conform to the current period's presentation. |
Adoption of New Accounting Pronouncements | Adoption of New Accounting Pronouncements There were no new accounting pronouncements adopted by the Company during the thirteen and twenty-six weeks ended July 30, 2022. |
Fair Value Measurements | FAIR VALUE MEASUREMENTS Our financial instruments generally consist of cash, money market accounts, marketable securities, assets held in our non-qualified deferred compensation plan, accounts receivable and payable, and debt. Cash, accounts receivable and accounts payable are carried at cost, less reserves for credit losses as applicable, which approximates their fair value due to the short-term nature of the instruments. Marketable securities are classified as available-for-sale and as of July 30, 2022, consisted of U.S. government agencies, corporate bonds and commercial paper, with $8.8 million of securities with maturity dates within one year or less and $6.5 million with maturity dates over one year. We consider all marketable securities available-for-sale, including those with maturity dates beyond 12 months, and therefore classify these securities within current assets on the unaudited condensed consolidated balance sheets, as applicable, as they were available to support current operational liquidity needs. Marketable securities are carried at fair value, with the unrealized holding gains and losses, net of income taxes, reflected in accumulated other comprehensive gain until realized, and any credit risk related losses recognized in net income during the period incurred. For the purposes of computing realized and unrealized gains and losses, cost is determined on a specific identification basis. Fair value is defined as the price that would be received to sell an a set or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. Entities are required to use a three-level hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows: Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 — Unadjusted quoted prices in active markets for similar assets or liabilities; or Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or Inputs other than quoted prices that are observable for the asset or liability Level 3 — Unobservable inputs for the asset or liability Assets Measured on a Recurring Basis We measure certain financial assets at fair value on a recurring basis, including our marketable securities, as applicable, which are classified as available-for-sale securities, certain cash equivalents, specifically our money market accounts and assets held in our non-qualified deferred compensation plan, as applicable. The money market accounts are valued based on quoted market prices in active markets. Our marketable securities are generally valued based on other observable inputs for those securities (including market corroborated pricing or other models that utilize observable inputs such as interest rates and yield curves) based on information provided by independent third-party pricing entities, except for U.S. government securities which are valued based on quoted market prices in active markets. The investments in our non-qualified deferred compensation plan are valued using quoted market prices and are included in other assets on our unaudited condensed consolidated balance sheets. Assets Measured on a Nonrecurring Basis From time to time, we measure certain assets at fair value on a nonrecurring basis when carrying value exceeds fair value. This includes the evaluation of long-lived assets, goodwill and other intangible assets for impairment using Company-specific assumptions which would fall within Level 3 of the fair value hierarchy. Assets that are measured at fair value on a nonrecurring basis are remeasured when carrying value exceeds fair value. Carrying value after impairment approximates fair value. We assess the carrying amount of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses market participant rents and a market participant discount rate to calculate the fair value of ROU assets. The Company uses discounted future cash flows of the asset or asset group using a discount rate that approximates the cost of capital of a market participant to quantify fair value for other long-lived assets within the asset group, which are primarily leasehold improvements. The asset group is defined as the lowest level for which identifiable cash flows are available and largely independent of the cash flows of other groups of assets, which for our retail stores, is primarily at the store level. To assess the fair value of goodwill, we have historically utilized both an income approach and a market approach. Inputs used to calculate the fair value based on the income approach primarily include estimated future cash flows, discounted at a rate that approximates the cost of capital of a market participant. Inputs used to calculate the fair value based on the market approach include identifying sales and EBITDA multiples based on guidelines for similar publicly traded companies and recent transactions. To assess the fair value of trademarks, we utilize a relief from royalty approach. Inputs used to calculate the fair value of the trademarks primarily include future sales projections, discounted at a rate that approximates the cost of capital of a market participant and an estimated royalty rate. |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 6 Months Ended |
Jul. 30, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following table disaggregates our operating segment revenue by brand, which we believe provides a meaningful depiction of the nature of our revenue. Amounts shown include licensing and wholesale revenue, which is not a significant component of total revenue, and is aggregated within the respective brands in the table below. Thirteen Weeks Ended Twenty-Six Weeks Ended July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Chico's $ 281,777 50.4 % $ 221,389 46.9 % $ 546,243 49.7 % $ 398,410 46.3 % WHBM 158,581 28.4 122,043 25.9 327,610 29.8 226,090 26.3 Soma 118,362 21.2 128,627 27.2 225,782 20.5 235,520 27.4 Total Net Sales $ 558,720 100.0 % $ 472,059 100.0 % $ 1,099,635 100.0 % $ 860,020 100.0 % |
Leases (Tables)
Leases (Tables) | 6 Months Ended |
Jul. 30, 2022 | |
Leases [Abstract] | |
Lease Cost | Operating lease expense was as follows: Thirteen Weeks Ended Twenty-Six Weeks Ended July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Operating lease cost (1) $ 54,247 $ 55,341 $ 107,663 $ 110,747 (1) For the thirteen and twenty-six weeks ended July 30, 2022, includes $9.6 million and $19.1 million, respectively, in variable lease costs. For the thirteen and twenty-six weeks ended July 31, 2021, includes $9.3 million and $19.2 million, respectively, in variable lease costs. Supplemental cash flow information related to operating leases was as follows: Twenty-Six Weeks Ended July 30, 2022 July 31, 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflows $ 103,508 $ 132,549 Right of use assets obtained in exchange for lease obligations, non-cash 54,336 24,297 |
Supplemental Balance Sheet Information Related to Operating Leases | Supplemental balance sheet information related to operating leases was as follows: July 30, 2022 January 29, 2022 July 31, 2021 Right of use assets $ 438,959 $ 463,077 $ 529,945 Current lease liabilities $ 165,345 $ 172,506 $ 163,376 Long-term lease liabilities 350,797 381,081 454,164 Total operating lease liabilities $ 516,142 $ 553,587 $ 617,540 Weighted Average Remaining Lease Term (years) 4.0 4.0 4.2 Weighted Average Discount Rate (1) 4.6 % 4.5 % 4.6 % |
Maturities of Operating Lease Liabilities | Maturities of operating lease liabilities as of July 30, 2022 were as follows: Fiscal Year Ending: January 28, 2023 $ 99,596 February 4, 2024 166,504 February 1, 2025 121,141 January 31, 2026 78,879 January 30, 2027 51,307 Thereafter 53,578 Total future minimum lease payments $ 571,005 Less imputed interest (54,863) Total $ 516,142 |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 6 Months Ended |
Jul. 30, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Restricted Stock Activity | Restricted stock award activity for the twenty-six weeks ended July 30, 2022 was as follows: Number of Weighted Unvested, beginning of period 5,140,240 $ 3.18 Granted 2,572,233 4.78 Vested (2,347,510) 3.26 Forfeited (341,303) 3.59 Unvested, end of period 5,023,660 3.93 Restricted stock unit activity for the twenty-six weeks ended July 30, 2022 was as follows: Number of Weighted Unvested, beginning of period 647,350 $ 2.38 Granted 47,468 4.74 Vested (288,600) 2.66 Unvested, end of period 406,218 2.46 |
Schedule of Performance-Based Restricted Stock Unit Activity | PSU activity for the twenty-six weeks ended July 30, 2022 was as follows: Number of Units/ Weighted Unvested, beginning of period 3,734,207 $ 2.24 Granted 1,082,050 3.85 Vested (1,697,130) 1.16 Forfeited (434,122) 2.96 Unvested, end of period 2,685,005 3.45 |
Income Per Share (Tables)
Income Per Share (Tables) | 6 Months Ended |
Jul. 30, 2022 | |
Earnings Per Share [Abstract] | |
Computation of Basic and Diluted Net Income Per Share | The following table sets forth the computation of net income per basic and diluted share shown on the face of the accompanying condensed consolidated statements of income: Thirteen Weeks Ended Twenty-Six Weeks Ended July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Numerator Net income $ 41,961 $ 26,187 $ 76,893 $ 17,258 Net income allocated to participating securities (166) (235) (348) (171) Net income available to common shareholders $ 41,795 $ 25,952 $ 76,545 $ 17,087 Denominator (000's) Weighted average common shares outstanding – basic 120,003 117,021 119,498 116,855 Dilutive effect of non-participating securities 3,894 5,703 4,082 4,367 Weighted average common and common equivalent shares outstanding – diluted 123,897 122,723 123,580 121,222 Net income per common share: Basic $ 0.35 $ 0.22 $ 0.64 $ 0.15 Diluted $ 0.34 $ 0.21 $ 0.62 $ 0.14 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jul. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Financial Assets Valued on a Recurring Basis | In accordance with the provisions of the guidance, we categorized our financial assets and liabilities which are valued on a recurring and nonrecurring basis, based on the priority of the inputs to the valuation technique for the instruments, as follows: Fair Value Measurements at the End of the Reporting Date Using Balance as of July 30, 2022 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring fair value measurements: Current Assets Cash equivalents: Money market accounts $ 35,195 $ 35,195 $ — $ — Marketable securities: U.S. government agencies 1,505 — 1,505 — Corporate bonds 5,948 — 5,948 — Commercial paper 7,848 — 7,848 — Deferred compensation plan 4,803 4,803 — — Total recurring fair value measurements $ 55,299 $ 39,998 $ 15,301 $ — Fair Value Measurements at the End of the Reporting Date Using Balance as of January 29, 2022 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring fair value measurements: Current Assets Cash equivalents: Money market accounts $ 25,396 $ 25,396 $ — $ — Noncurrent Assets Deferred compensation plan 6,233 6,233 — — Total recurring fair value measurements $ 31,629 $ 31,629 $ — $ — Fair Value Measurements at the End of the Reporting Date Using Balance as of July 31, 2021 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring fair value measurements: Current Assets Cash equivalents: Money market accounts $ 14,493 $ 14,493 $ — $ — Marketable securities: Corporate bonds 10,891 — 10,891 — Noncurrent Assets Deferred compensation plan 6,124 6,124 — — Total recurring fair value measurements $ 31,508 $ 20,617 $ 10,891 $ — |
Revenue Recognition (Details)
Revenue Recognition (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jul. 30, 2022 | Jul. 31, 2021 | Jul. 30, 2022 | Jul. 31, 2021 | Jan. 29, 2022 | |
Disaggregation of Revenue [Line Items] | |||||
Total Net Sales | $ 558,720 | $ 472,059 | $ 1,099,635 | $ 860,020 | |
Total Net Sales, as a percentage | 100% | 100% | 100% | 100% | |
Contract liabilities | $ 33,700 | $ 33,800 | $ 33,700 | $ 33,800 | $ 43,500 |
Contract liability revenue recognized | 8,500 | 5,700 | 20,000 | 15,700 | |
Chico's | |||||
Disaggregation of Revenue [Line Items] | |||||
Total Net Sales | $ 281,777 | $ 221,389 | $ 546,243 | $ 398,410 | |
Total Net Sales, as a percentage | 50.40% | 46.90% | 49.70% | 46.30% | |
WHBM | |||||
Disaggregation of Revenue [Line Items] | |||||
Total Net Sales | $ 158,581 | $ 122,043 | $ 327,610 | $ 226,090 | |
Total Net Sales, as a percentage | 28.40% | 25.90% | 29.80% | 26.30% | |
Soma | |||||
Disaggregation of Revenue [Line Items] | |||||
Total Net Sales | $ 118,362 | $ 128,627 | $ 225,782 | $ 235,520 | |
Total Net Sales, as a percentage | 21.20% | 27.20% | 20.50% | 27.40% |
Leases - Lease Costs (Details)
Leases - Lease Costs (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 30, 2022 | Jul. 31, 2021 | Jul. 30, 2022 | Jul. 31, 2021 | |
Leases [Abstract] | ||||
Operating lease cost | $ 54,247 | $ 55,341 | $ 107,663 | $ 110,747 |
Variable lease cost | $ 9,600 | $ 9,300 | $ 19,100 | $ 19,200 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information Related to Operating Leases (Details) - USD ($) $ in Thousands | Jul. 30, 2022 | Jan. 29, 2022 | Jul. 31, 2021 |
Leases [Abstract] | |||
Right of use assets | $ 438,959 | $ 463,077 | $ 529,945 |
Current lease liabilities | 165,345 | 172,506 | 163,376 |
Long-term lease liabilities | 350,797 | 381,081 | 454,164 |
Total operating lease liabilities | $ 516,142 | $ 553,587 | $ 617,540 |
Weighted Average Remaining Lease Term (years) | 4 years | 4 years | 4 years 2 months 12 days |
Weighted Average Discount Rate | 4.60% | 4.50% | 4.60% |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jul. 30, 2022 | Jul. 31, 2021 | |
Cash paid for amounts included in the measurement of lease liabilities: | ||
Operating cash outflows | $ 103,508 | $ 132,549 |
Right of use assets obtained in exchange for lease obligations, non-cash | $ 54,336 | $ 24,297 |
Leases - Maturities of Operatin
Leases - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands | Jul. 30, 2022 | Jan. 29, 2022 | Jul. 31, 2021 |
Lessee, Operating Lease, Liability, Payment, Due [Abstract] | |||
January 28, 2023 | $ 99,596 | ||
February 4, 2024 | 166,504 | ||
February 1, 2025 | 121,141 | ||
January 31, 2026 | 78,879 | ||
January 30, 2027 | 51,307 | ||
Thereafter | 53,578 | ||
Total future minimum lease payments | 571,005 | ||
Less imputed interest | (54,863) | ||
Total | $ 516,142 | $ 553,587 | $ 617,540 |
Share-Based Compensation - Addi
Share-Based Compensation - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions | 1 Months Ended | 6 Months Ended | |
Mar. 31, 2022 | Jul. 30, 2022 | Jul. 31, 2021 | |
Share-Based Payment Arrangement [Abstract] | |||
Compensation expense related to stock-based awards | $ 7,157 | $ 5,689 | |
Number of shares available for future grants (in shares) | 6.6 | ||
Restricted Stock Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 3 years | ||
Restricted Stock Awards | CEO | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 4 years | ||
Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 3 years | 1 year | |
Vesting percentage | 100% | ||
Performance-Based Restricted Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 3 years | ||
Tranche One | Restricted Stock Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting percentage | 50% | ||
Tranche One | Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting percentage | 50% | ||
Tranche Two | Restricted Stock Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting percentage | 30% | ||
Tranche Two | Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting percentage | 30% | ||
Tranche Three | Restricted Stock Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting percentage | 20% | ||
Tranche Three | Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting percentage | 20% |
Share-Based Compensation - Summ
Share-Based Compensation - Summary of Restricted Stock Awards and Performance-based Restricted Stock Unit Activity (Details) | 6 Months Ended |
Jul. 30, 2022 $ / shares shares | |
Restricted Stock Awards | |
Number of Units/ Shares | |
Unvested, beginning of period (in shares) | shares | 5,140,240 |
Granted (in shares) | shares | 2,572,233 |
Vested (in shares) | shares | (2,347,510) |
Forfeited (in shares) | shares | (341,303) |
Unvested, end of period (in shares) | shares | 5,023,660 |
Weighted Average Grant Date Fair Value | |
Unvested, beginning of period (in dollars per share) | $ / shares | $ 3.18 |
Granted (in dollars per share) | $ / shares | 4.78 |
Vested (in dollars per share) | $ / shares | 3.26 |
Forfeited (in dollars per share) | $ / shares | 3.59 |
Unvested, end of period (in dollars per share) | $ / shares | $ 3.93 |
Restricted Stock Units (RSUs) | |
Number of Units/ Shares | |
Unvested, beginning of period (in shares) | shares | 647,350 |
Granted (in shares) | shares | 47,468 |
Vested (in shares) | shares | (288,600) |
Unvested, end of period (in shares) | shares | 406,218 |
Weighted Average Grant Date Fair Value | |
Unvested, beginning of period (in dollars per share) | $ / shares | $ 2.38 |
Granted (in dollars per share) | $ / shares | 4.74 |
Vested (in dollars per share) | $ / shares | 2.66 |
Unvested, end of period (in dollars per share) | $ / shares | $ 2.46 |
Performance-Based Restricted Stock Units | |
Number of Units/ Shares | |
Unvested, beginning of period (in shares) | shares | 3,734,207 |
Granted (in shares) | shares | 1,082,050 |
Vested (in shares) | shares | (1,697,130) |
Forfeited (in shares) | shares | (434,122) |
Unvested, end of period (in shares) | shares | 2,685,005 |
Weighted Average Grant Date Fair Value | |
Unvested, beginning of period (in dollars per share) | $ / shares | $ 2.24 |
Granted (in dollars per share) | $ / shares | 3.85 |
Vested (in dollars per share) | $ / shares | 1.16 |
Forfeited (in dollars per share) | $ / shares | 2.96 |
Unvested, end of period (in dollars per share) | $ / shares | $ 3.45 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Jul. 30, 2022 | Jul. 31, 2021 | Jul. 30, 2022 | Jul. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||||
Effective tax rate | 26.60% | 22.70% | 24.30% | 30% |
Income tax receivable | $ 11.4 | $ 11.4 |
Income Per Share - Computation
Income Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 30, 2022 | Jul. 31, 2021 | Jul. 30, 2022 | Jul. 31, 2021 | |
Numerator | ||||
Net income | $ 41,961 | $ 26,187 | $ 76,893 | $ 17,258 |
Net income allocated to participating securities | (166) | (235) | (348) | (171) |
Net income available to common shareholders | $ 41,795 | $ 25,952 | $ 76,545 | $ 17,087 |
Denominator (000's) | ||||
Weighted average common shares outstanding – basic (in shares) | 120,003 | 117,021 | 119,498 | 116,855 |
Dilutive effect of non-participating securities (in shares) | 3,894 | 5,703 | 4,082 | 4,367 |
Weighted average common and common equivalent shares outstanding – diluted (in shares) | 123,897 | 122,723 | 123,580 | 121,222 |
Net income per common share: | ||||
Basic (in dollars per share) | $ 0.35 | $ 0.22 | $ 0.64 | $ 0.15 |
Diluted (in dollars per share) | $ 0.34 | $ 0.21 | $ 0.62 | $ 0.14 |
Income Per Share - Additional I
Income Per Share - Additional Information (Details) - shares shares in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 30, 2022 | Jul. 31, 2021 | Jul. 30, 2022 | Jul. 31, 2021 | |
Earnings Per Share [Abstract] | ||||
Number of antidilutive securities (in shares) | 50 | 100 | 100 | 100 |
Fair Value Measurements - Finan
Fair Value Measurements - Financial Assets Valued on a Recurring Basis (Details) - USD ($) $ in Thousands | Jul. 30, 2022 | Jan. 29, 2022 | Jul. 31, 2021 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
AFS securities, current | $ 8,800 | ||
AFS securities, noncurrent | 6,500 | ||
Recurring | |||
Current Assets | |||
Money market accounts | 35,195 | $ 25,396 | $ 14,493 |
Noncurrent Assets | |||
Deferred compensation plan | 4,803 | 6,233 | 6,124 |
Total recurring fair value measurements | 55,299 | 31,629 | 31,508 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | |||
Current Assets | |||
Money market accounts | 35,195 | 25,396 | 14,493 |
Noncurrent Assets | |||
Deferred compensation plan | 4,803 | 6,233 | 6,124 |
Total recurring fair value measurements | 39,998 | 31,629 | 20,617 |
Recurring | Significant Other Observable Inputs (Level 2) | |||
Current Assets | |||
Money market accounts | 0 | 0 | 0 |
Noncurrent Assets | |||
Deferred compensation plan | 0 | 0 | 0 |
Total recurring fair value measurements | 15,301 | 0 | 10,891 |
Recurring | Significant Unobservable Inputs (Level 3) | |||
Current Assets | |||
Money market accounts | 0 | 0 | 0 |
Noncurrent Assets | |||
Deferred compensation plan | 0 | 0 | 0 |
Total recurring fair value measurements | 0 | $ 0 | 0 |
Recurring | U.S. government agencies | |||
Current Assets | |||
Marketable securities | 1,505 | ||
Recurring | U.S. government agencies | Quoted Prices in Active Markets for Identical Assets (Level 1) | |||
Current Assets | |||
Marketable securities | 0 | ||
Recurring | U.S. government agencies | Significant Other Observable Inputs (Level 2) | |||
Current Assets | |||
Marketable securities | 1,505 | ||
Recurring | U.S. government agencies | Significant Unobservable Inputs (Level 3) | |||
Current Assets | |||
Marketable securities | 0 | ||
Recurring | Corporate bonds | |||
Current Assets | |||
Marketable securities | 5,948 | 10,891 | |
Recurring | Corporate bonds | Quoted Prices in Active Markets for Identical Assets (Level 1) | |||
Current Assets | |||
Marketable securities | 0 | 0 | |
Recurring | Corporate bonds | Significant Other Observable Inputs (Level 2) | |||
Current Assets | |||
Marketable securities | 5,948 | 10,891 | |
Recurring | Corporate bonds | Significant Unobservable Inputs (Level 3) | |||
Current Assets | |||
Marketable securities | 0 | $ 0 | |
Recurring | Commercial paper | |||
Current Assets | |||
Marketable securities | 7,848 | ||
Recurring | Commercial paper | Quoted Prices in Active Markets for Identical Assets (Level 1) | |||
Current Assets | |||
Marketable securities | 0 | ||
Recurring | Commercial paper | Significant Other Observable Inputs (Level 2) | |||
Current Assets | |||
Marketable securities | 7,848 | ||
Recurring | Commercial paper | Significant Unobservable Inputs (Level 3) | |||
Current Assets | |||
Marketable securities | $ 0 |
Debt - Additional Information (
Debt - Additional Information (Details) - Revolving credit facility - USD ($) | Feb. 02, 2022 | Jul. 30, 2022 |
Line of credit | ||
Debt Instrument [Line Items] | ||
Long-term debt, term | 5 years | |
Borrowing capacity | $ 285,000,000 | |
Long-term debt | $ 99,000,000 | |
Additional borrowing capacity | 188,000,000 | |
Excess availability of borrowing | 30,000,000 | |
Deferred financing costs | $ 3,700,000 | |
Line of credit | SOFR | ||
Debt Instrument [Line Items] | ||
Interest rate | 1.60% | |
Line of credit | SOFR | Minimum | ||
Debt Instrument [Line Items] | ||
Interest rate | 1.35% | |
Line of credit | SOFR | Maximum | ||
Debt Instrument [Line Items] | ||
Interest rate | 1.85% | |
FILO | ||
Debt Instrument [Line Items] | ||
Borrowing capacity | $ 15,000,000 | |
Basis points | 0.30% | |
FILO | Maximum | ||
Debt Instrument [Line Items] | ||
Interest rate | 3.85% | |
FILO | SOFR | ||
Debt Instrument [Line Items] | ||
Interest rate | 3.60% | |
FILO | SOFR | Minimum | ||
Debt Instrument [Line Items] | ||
Interest rate | 3.35% |